Highlighting the most relevant, up-to-date and cutting-edge science, Digestive Disease Week® (DDW) is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology,
Digestive Disease Week® (DDW) Administration is in the thick of planning the 2018 meeting. We hope you can join us in Washington, DC, June 2-5, for
Join us in Washington, D.C., June 2-8 for Digestive Disease Week® (DDW) 2018. Recognized as a top 50 medical meeting, this is your opportunity to
Alcoholic liver disease (ALD) is one of the leading causes of morbidity and mortality in the U.S. and worldwide. Three hepatologists discussed the management of
An AASLD symposium on the final day of DDW® 2017 brought together experts from around the world to discuss pharmacological therapies, endoscopic therapies, interventional procedures
DDW TV spoke with speaker Michael W. Fried, MD, FAASLD, about the incredible strides made in the treatment of hepatitis C – and how to
Andrew P. Keaveny, MD, FRCPI, FAASLD
Consultant Hepatologist and Medical Director of Liver Transplant, Mayo Clinic, Jacksonville, Florida; Associate Professor of Medicine, Mayo Clinic College of Medicine and Science; Chair, AASLD Annual Meeting Education Committee; Member of the AASLD Maintenance of Certification and Scientific Planning Committees
Adequate nutrition is important for growth and meeting developmental milestones for all children. But for pediatric liver patients, overnutrition or undernutrition can have devastating effects.
Patients who are hospitalized with cirrhosis are in trouble. They may have hepatic encephalopathy leading to impaired mentation and possible coma. They may have acute kidney injury that requires a liver transplant. They may have portal hypertension leading to ascites and spontaneous bacterial peritonitis. And they may have potentially fatal variceal bleeding.
Four experts will discuss the management for nonalcoholic fatty liver disease (NAFLD) and its progression to nonalcoholic steatohepatitis (NASH) during Tuesday’s AASLD Clinical Symposium Identification and Management of Patients with NAFLD/NASH.
